iBio reports plans to price public offering of common-share units

Company sells units of shares, three-year warrants via Roth Capital

By Devika Patel

Knoxville, Tenn., April 22 - iBio, Inc. will price a public sale of its units, according to a prospectus supplement filed Monday with the Securities and Exchange Commission.

The units will consist of one common share and a 0.4 warrants. The whole warrants will be exercisable for three years.

Roth Capital Partners is assisting.

Proceeds will be used for working capital, including development of the company's product candidate and proprietary technology, business development and other general corporate purposes.

The biotechnology company is based in Newark, Del.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.